Seelos Therapeutics, Inc. (SEEL)

1.28 0.00 (0.00%) USD  |  NASDAQ  |  Sep 08, 16:00
More

Seelos Therapeutics PE Ratio

PE Ratio Chart

View PE Ratio for SEEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PE Ratio Chart
Start Trial

Historical PE Ratio Data

View and export this data back to 2024. Start Trial.
Date Value
December 30, 2024 0.0072
December 27, 2024 0.0072
December 26, 2024 0.0072
December 24, 2024 0.0072
December 23, 2024 0.0072
December 20, 2024 0.0072
December 19, 2024 0.0072
December 18, 2024 0.0072
December 17, 2024 0.0072
December 16, 2024 0.0072
December 13, 2024 0.0072
December 12, 2024 0.0072
December 11, 2024 0.0072
December 10, 2024 0.0072
December 09, 2024 0.0072
December 06, 2024 0.0072
December 05, 2024 0.0072
December 04, 2024 0.0072
December 03, 2024 0.0072
December 02, 2024 0.0072
November 29, 2024 0.0072
November 27, 2024 0.0072
November 26, 2024 0.0072
November 25, 2024 0.0072
November 22, 2024 0.0072
Date Value
November 21, 2024 0.0072
November 20, 2024 0.0072
November 19, 2024 0.0072
November 18, 2024 0.0072
November 15, 2024 0.0072
November 14, 2024 0.0072
November 13, 2024 0.0072
November 12, 2024 0.0072
November 11, 2024 0.0072
November 08, 2024 0.0072
November 07, 2024 0.0072
November 06, 2024 0.0072
November 05, 2024 0.0072
November 04, 2024 0.0072
November 01, 2024 0.0072
October 31, 2024 0.0072
October 30, 2024 0.0072
October 29, 2024 0.0072
October 28, 2024 0.0072
October 25, 2024 0.0072
October 24, 2024 0.0072
October 23, 2024 0.0072
October 22, 2024 0.0072
October 21, 2024 0.0072
October 18, 2024 0.0072

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

View PE Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PE Ratio Benchmarks

View PE Ratio Benchmarks
Start Trial
Filana Therapeutics, Inc. --
CorMedix, Inc. 3.882
Eloxx Pharmaceuticals, Inc. --
Cannabis Global, Inc. --
Breakthrough Chemistry, Inc. --

PE Ratio Related Metrics

Price 1.28
Market Cap 0.2657M